Cargando…
Participant uptake of the fecal immunochemical test decreases with the two-sample regimen compared with one-sample FIT
BACKGROUND: Fecal immunochemical tests (FITs) are recommended to screen average-risk adults for colorectal cancer (CRC). Little research has examined whether a two-sample FIT affects participant uptake, compared with a one-sample FIT. Examining participant uptake is important, as evidence suggests t...
Autores principales: | Mosen, David M., Liles, Elizabeth G., Feldstein, Adrianne C., Perrin, Nancy, Rosales, Anna G., Keast, Erin, Smith, David H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186737/ https://www.ncbi.nlm.nih.gov/pubmed/25203483 http://dx.doi.org/10.1097/CEJ.0000000000000084 |
Ejemplares similares
-
Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study
por: Liles, Elizabeth G., et al.
Publicado: (2018) -
Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial
por: Nielson, Carrie M., et al.
Publicado: (2018) -
Implementation challenges and successes of a population-based colorectal cancer screening program: a qualitative study of stakeholder perspectives
por: Liles, Elizabeth G, et al.
Publicado: (2015) -
Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers
por: Schunke, Kathryn J., et al.
Publicado: (2017) -
Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
por: Catenacci, Daniel V., et al.
Publicado: (2021)